Navitas stock soars as company advances 800V tech for NVIDIA AI platforms
LOS ANGELES - Private equity firm Platinum Equity announced Tuesday it has entered into a definitive agreement to acquire the Products & Healthcare Services (P&HS) segment from Owens & Minor (NYSE:OMI), with the healthcare company retaining a 5% equity stake in the business.
The Richmond, Virginia-based P&HS is a medical supply distribution platform primarily serving the acute care market, distributing medical and surgical supplies to hospitals and healthcare providers across the United States.
"Owens & Minor has played a vital role in supporting healthcare providers and patients across the country, and we are proud to invest in the future of P&HS," said Jacob Kotzubei, Co-President of Platinum Equity, in a press release statement.
Edward A. Pesicka, President and CEO of Owens & Minor, called Platinum Equity "the perfect home for the Products & Healthcare Services business."
Platinum Equity, which has approximately $50 billion of assets under management, highlighted its experience with carve-out transactions, having previously acquired businesses from companies including Ball Corporation, Caterpillar, and Emerson Electric.
Matthew Louie, Managing Director at Platinum Equity, pointed to favorable demographic trends as a key factor in the acquisition. "We believe the aging U.S. population and increasing demand for healthcare services will continue to drive sustainable long-term demand for medical supplies distribution," he said.
The transaction is expected to close near the end of 2025, subject to regulatory review and other customary closing conditions. With the company’s current ratio at 0.86 and rapid cash burn rate, this strategic move could help strengthen its financial position. Discover more detailed insights about OMI and 1,400+ other stocks through InvestingPro’s comprehensive Research Reports.
Bank of America and Fifth Third are serving as financial advisors to Platinum Equity, while Citi and Wells Fargo are advising Owens & Minor on the transaction.
In other recent news, Owens & Minor Inc. reported its second-quarter 2025 earnings, revealing earnings per share of $0.26, which fell short of the anticipated $0.29. The company’s revenue for the quarter reached $682 million, representing a 3.3% increase from the previous year. Additionally, Owens & Minor has announced a definitive agreement to sell its Products & Healthcare Services segment to Platinum Equity for $375 million in cash, along with retaining a 5% equity stake and potential future proceeds. The transaction is expected to close by the end of 2025. In other developments, Snehashish Sarkar, executive vice president and chief information officer, will resign effective September 26, 2025, to pursue another opportunity. UBS has lowered its price target for Owens & Minor to $7.00, citing a disappointing outlook and near-term dis-synergies from the P&HS sale. Despite maintaining a Buy rating, UBS noted potential proceeds from the sale could help reduce the company’s debt. These recent developments highlight the company’s ongoing strategic changes and financial challenges.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.